Suppr超能文献

丙磺舒-氯贝丁酯相互作用。

Probenecid-clofibrate interaction.

作者信息

Veenendaal J R, Brooks P M, Meffin P J

出版信息

Clin Pharmacol Ther. 1981 Mar;29(3):351-8. doi: 10.1038/clpt.1981.48.

Abstract

Clofibric acid disposition was studied in four healthy men after 1 wk of clofibrate ingestion (500 mg orally every 12 hr) with and without probenecid (500 mg orally every 6 hr). Mean (+/- SD) free clofibric acid plasma concentration in the four subjects over a dosage interval at steady state was 2.5 +/- 0.03 mg/1 before and 9.05 +/- 1.09 mg/1 after the probenecid. Probenecid reached an average plasma concentration of 71.3 mg/1. No clofibric acid glucuronide was detected in plasma during either treatment. The fractions of the dose recovered in urine as clofibric acid, clofibric acid glucuronide, and clofibric acid liberated after acid hydrolysis were not altered by probenecid. These data suggest that probenecid causes a reduction in renal and metabolic clearance of clofibric acid, probably as a result of inhibition of the conjugation of clofibric acid with glucuronide.

摘要

在四名健康男性中研究了氯贝酸的处置情况。这些男性在服用氯贝丁酯(每12小时口服500毫克)1周后,分别在有和没有丙磺舒(每6小时口服500毫克)的情况下进行实验。在稳态时,四名受试者在一个给药间隔内的游离氯贝酸血浆平均浓度(±标准差)在服用丙磺舒前为2.5±0.03毫克/升,服用后为9.05±1.09毫克/升。丙磺舒的平均血浆浓度达到71.3毫克/升。在两种治疗期间,血浆中均未检测到氯贝酸葡糖醛酸。尿液中作为氯贝酸、氯贝酸葡糖醛酸以及酸水解后释放的氯贝酸回收的剂量分数未因丙磺舒而改变。这些数据表明,丙磺舒导致氯贝酸的肾脏清除率和代谢清除率降低,这可能是由于抑制了氯贝酸与葡糖醛酸的结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验